Anti-clastogenic effect of beta-glucan extracted from barley towards chemically induced DNA damage in rodent cells


Autoria(s): Angeli, J. P. F.; Ribeiro, L. R.; Bellini, M. F.; Mantovani, M. S.
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

20/05/2014

20/05/2014

01/06/2006

Resumo

beta-Glucan (BG) was tested in vitro to determine its potential clastogenic and/or anti-clastogenic activity, and attempts were made to elucidate its possible mechanism of action by using combinations with an inhibitor of DNA polymerase. The study was carried out on cells deficient (CHO-k1) and cells proficient (HTC) in phases I and II enzymes, and the DNA damage was assessed by the chromosomal aberration assay. BG did not show a clastogenic effect, but was anti-clastogenic in both cell lines used, and at all concentrations tested (2.5, 5 and 10 mg/mL) in combination with damage inducing agents (methylmethane sulfonate in cell line CHO-k1, and methylmethane sulfonate or 2-aminoanthracene in cell line HTC). BG also showed a protective effect in the presence of a DNA polymerase beta inhibitor (cytosine arabinoside-3-phosphate, Ara-C), demonstrating that BG does not act through an anti-mutagenic mechanism of action involving DNA polymerase beta.

Formato

319-324

Identificador

http://dx.doi.org/10.1191/0960327106ht631oa

Human & Experimental Toxicology. London: Hodder Arnold, Hodder Headline Plc, v. 25, n. 6, p. 319-324, 2006.

0960-3271

http://hdl.handle.net/11449/19426

10.1191/0960327106ht631oa

WOS:000238439300005

Idioma(s)

eng

Publicador

Hodder Arnold, Hodder Headline Plc

Relação

Human & Experimental Toxicology

Direitos

closedAccess

Palavras-Chave #anti-mutagenesis #beta-glucans #chromosomal aberrations #drug-metabolizing cells
Tipo

info:eu-repo/semantics/article